A Multicenter, Randomized, Open-Label Trial: Efficacy of Once-Daily Versus Twice-Daily Double-Dose Rabeprazole on Refractory Gastroesophageal Reflux Disease-Related Symptoms and Quality of Life.

Mizuki, Akira; Tatemichi, Masayuki; Sakakibara, Terue; Miura, Yukihiko; Zeki, Shigeyuki; Ohata, Mitsuru; Matsuo, Kenji; Kawamura, Fumio; Nagata, Hiroshi

Mizuki, Akira; Tatemichi, Masayuki; Sakakibara, Terue; Miura, Yukihiko; Zeki, Shigeyuki; Ohata, Mitsuru; Matsuo, Kenji; Kawamura, Fumio; Nagata, Hiroshi.

Afiliação

Mizuki A; Department of Internal Medicine, Keiyu Hospital, Yokohama, Japan.
Tatemichi M; Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Japan.
Sakakibara T; Sakakibara Clinic, Yokohama, Japan.
Miura Y; Minatomirai Naika Clinic, Yokohama, Japan.
Zeki S; Tokui Medical Clinic, Yokohama, Japan.
Ohata M; Hiranuma Clinic, Yokohama, Japan.
Matsuo K; Matsuo Clinic, Yokohama, Japan.
Kawamura F; Kawamura Clinic, Yokohama, Japan.
Nagata H; Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Japan.

Curr Ther Res Clin Exp ; 79: 1-7, 2016.

Article em En | MEDLINE | ID: mdl-28066515

Palavras-chave

proton-pump inhibitor; quality of life; refractory gastroesophageal reflux disease; sleep disturbances

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Idioma: En Revista: Curr Ther Res Clin Exp Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google